| |
Opportunities for niche players in the combinatori Pharmaceutical companies direct R&D investment is being increasingly focused on the core business - leaving space for niche suppliers in areas such as combinatorial chemistry. Linda Hugl, Ian Matthews and Alan Stuttle, ChemOva (June 2000)
Keywords: chemical assay, camd, compound management systems, hplc, histology, chromatography, luminescence, electrophoresis, ftir, luminescence technology, molecule development, microscopy, nature, quantitative neuroimaging, screening, radio-labelled studies, research, spectroscopy, lc-gc, synthesis, microscopy and analysis, laboratory, molecules, ChemOvation Ltd, Jeté, R&D
|
